Editorial
Published on 10 Nov 2022
Editorial: How pharmacogenomics, epigenetics, and data analysis could improve anticancer treatment?
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1067022
- 1,709 views
Type at least 3 characters
551 articles
Articles
Original Research
Published on 09 Nov 2022
SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1042989
- 2,780 views
- 2 citations
Review
Published on 04 Nov 2022
Relationship between miRNA and ferroptosis in tumors
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.977062
- 5,003 views
- 24 citations
Original Research
Published on 28 Oct 2022
Acetyl coenzyme A kinetic studies on N-acetylation of environmental carcinogens by human N-acetyltransferase 1 and its NAT1*14B variant
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.931323
- 1,753 views
- 1 citation
Original Research
Published on 26 Oct 2022
The association of ARRB1 polymorphisms with response to antidepressant treatment in depressed patients
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.974570
- 1,883 views
- 7 citations
Original Research
Published on 24 Oct 2022
Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1029073
- 4,658 views
- 4 citations
Original Research
Published on 14 Oct 2022
Pharmacogenomic-guided clozapine administration based on HLA-DQB1, HLA-B and SLCO1B3-SLCO1B7 variants: an effectiveness and cost-effectiveness analysis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1016669
- 2,582 views
- 3 citations
Original Research
Published on 07 Oct 2022
Association of ABCC2 polymorphism with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.889473
- 1,913 views
- 3 citations
Original Research
Published on 05 Oct 2022
Variant predictions in congenital adrenal hyperplasia caused by mutations in CYP21A2
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.931089
- 3,679 views
- 4 citations
Original Research
Published on 03 Oct 2022
Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorder
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.984383
- 5,081 views
- 6 citations
Opinion
Published on 26 Sep 2022
Pharmacogenomics at the post-pandemic: If not now, then when?
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1013527
- 1,713 views
Original Research
Published on 23 Sep 2022
A genome-wide association study of plasma concentrations of warfarin enantiomers and metabolites in sub-Saharan black-African patients
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.967082
- 4,351 views
- 11 citations
Original Research
Published on 23 Sep 2022
TPMT and NUDT15 testing for thiopurine therapy: A major tertiary hospital experience and lessons learned
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.837164
- 8,191 views
- 9 citations
Original Research
Published on 21 Sep 2022
Community pharmacists’ perceived value on precision medicine, desired training components, and exposure during pharmacy education: Malaysia’s experience
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.978141
- 3,528 views
- 2 citations
Original Research
Published on 20 Sep 2022
Bioinformatics and network-based screening and discovery of potential molecular targets and small molecular drugs for breast cancer
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.942126
- 9,701 views
- 13 citations
Original Research
Published on 15 Sep 2022
Systematic evaluation of irinotecan-induced intestinal mucositis based on metabolomics analysis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2022.958882
- 5,663 views
- 1 citation